Cervical cancer (CC) remains a current global issue, with> 90% of cervical cancer cases
being attributed to human papilloma virus (HPV). The highest burden of cervical cancer is …

Background Cervical cancer is a significant public health problem, with 570,000 new cases
and 300,000 deaths of women per year globally, mostly in low-and middle-income countries …

In most high‐resource countries with organized screening programs, the incidence and
mortality of cervical cancer is decreasing. Recent statistics have also revealed a reduction in …

Human papillomavirus (HPV)-associated cancers, including oropharyngeal squamous cell
carcinoma (HPV+ OPSCC), cervical cancer, and squamous cell carcinoma of the anus …

Background: In this study, we evaluated accuracy of HPV testing on self-samples versus
clinician-taken samples through the VALHUDES protocol. VALHUDES was designed as a …

Purpose Cervical cancer (CC) is a major risk for health of modern women. Immune-related
long non-coding RNAs (lncRNAs) can also serve as prognostic markers of overall survival …

The VALHUDES framework (NCT03064087) was established to evaluate the clinical
accuracy of HPV testing on self-samples compared with HPV testing on matched clinician …

The first step in evaluating the effectiveness of cervical screening is defining exposure to
screening. Our aim was to describe the spectrum of screening exposure definitions used in …

Background Interventions to reach women who do not participate regularly in screening may
reduce the risk of cervical cancer. Self-collection of a vaginal specimen has been shown to …

Simple Summary Opportunistic cervical testing is a common practice in many countries.
However, quality control of tests outside national screening programs is often not possible …